Literature DB >> 8578030

The symptom experience of alopecia.

S Pickard-Holley1.   

Abstract

OBJECTIVES: To examine the physiology and pathophysiology of loss of hair, the impact of alopecia on the patient, nursing and self-care interventions, and available resources. DATA SOURCES: Published articles pertaining to alopecia and personal experiences of coping with alopecia.
CONCLUSIONS: Hair loss often is the most traumatic side effect for cancer patients. It causes depression, loss of self-confidence, and humiliation in men and women of all ages. Too few studies exist to make a definitive recommendation for scalp hypothermia and the use of scalp tourniquets. The major controversy and issue to consider with these hair-preservation techniques is scalp metastases. Further studies are needed to identify the impact of alopecia on patient self-image and quality of life. IMPLICATIONS FOR NURSING PRACTICE: Nursing interventions should be directed toward helping the patient and family adapt to and cope with alopecia. Patient education, identification of available resources, and supportive listening are therapeutic interventions.

Entities:  

Mesh:

Year:  1995        PMID: 8578030     DOI: 10.1016/s0749-2081(05)80003-8

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  10 in total

Review 1.  Protection against chemotherapy-induced alopecia.

Authors:  Jie Wang; Ze Lu; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-11       Impact factor: 4.200

2.  An evaluation of a computer-imaging program to prepare women for chemotherapy-related alopecia.

Authors:  Elizabeth L McGarvey; Maguadalupe Leon-Verdin; Lora D Baum; Karen Bloomfield; David R Brenin; Cheryl Koopman; Scott Acton; Brian Clark; B Eugene Parker
Journal:  Psychooncology       Date:  2010-07       Impact factor: 3.894

Review 3.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

4.  Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy.

Authors:  I G Ron; Y Kalmus; Z Kalmus; M Inbar; S Chaitchik
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

5.  Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.

Authors:  Floortje Mols; Corina J van den Hurk; Ad J J M Vingerhoets; Wim P M Breed
Journal:  Support Care Cancer       Date:  2008-06-17       Impact factor: 3.603

Review 6.  Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches.

Authors:  Paul J Hesketh; Diane Batchelor; Mitch Golant; Gary H Lyman; Nelson Rhodes; Denise Yardley
Journal:  Support Care Cancer       Date:  2004-06-19       Impact factor: 3.603

Review 7.  Hormonal therapy in female pattern hair loss.

Authors:  Kevin R Brough; Rochelle R Torgerson
Journal:  Int J Womens Dermatol       Date:  2017-02-24

8.  An Observational Study of Anticipatory Coping Behavior of Women for Chemotherapy-Induced Alopecia for Breast Cancer Treatment.

Authors:  Deepak Raj G; Oseen Shaikh; Uday Kumbhar; Sudharsanan Sundaramurthi; Vikas Menon; Chellappa Vijayakumar
Journal:  Cureus       Date:  2022-09-12

9.  EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients.

Authors:  Franz-Ferdinand Bitto; Alexander König; Thuy Phan-Brehm; Thomas Vallbracht; Julian Gregor Koch; Timo Schinköthe; Matthias Wolfgarten; Sven Mahner; Nadia Harbeck; Rachel Würstlein
Journal:  Breast Care (Basel)       Date:  2019-07-25       Impact factor: 2.860

10.  Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake.

Authors:  Christopher Dunnill; Khalidah Ibraheem; Michael Peake; Myria Ioannou; Megan Palmer; Adrian Smith; Andrew Collett; Nikolaos T Georgopoulos
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.